Carisma, Moderna Expand In Vivo Cell Therapy Collaboration to Autoimmune Diseases

In a partnership with Moderna, now expanded to two undisclosed autoimmune targets, Carisma Therapeutics hopes to seriously simplify cell therapy by bypassing the need to culture patient cells out of the body.